These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Griebsch I, Coast J, Brown J. Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026 [Abstract] [Full Text] [Related]
4. Test-retest reliability of health state valuation techniques: the time trade off and person trade off. Robinson S. Health Econ; 2011 Nov; 20(11):1379-91. PubMed ID: 21053203 [Abstract] [Full Text] [Related]
11. Valuing quality of life: results for New Zealand health professionals. Devlin N, Williams A. N Z Med J; 1999 Mar 12; 112(1083):68-71. PubMed ID: 10210306 [Abstract] [Full Text] [Related]
12. Preferences for health outcomes and cost-utility analysis. Torrance GW. Am J Manag Care; 1997 May 12; 3 Suppl():S8-20. PubMed ID: 10180342 [Abstract] [Full Text] [Related]
13. Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories. Dale W, Basu A, Elstein A, Meltzer D. Med Decis Making; 2008 May 12; 28(1):102-12. PubMed ID: 18057188 [Abstract] [Full Text] [Related]
16. On the societal value of health care: what do we know about the person trade-off technique? Green C. Health Econ; 2001 Apr 12; 10(3):233-43. PubMed ID: 11288189 [Abstract] [Full Text] [Related]
17. Does it matter who you are or what you gain? An experimental study of preferences for resource allocation. Schwappach DL. Health Econ; 2003 Apr 12; 12(4):255-67. PubMed ID: 12652513 [Abstract] [Full Text] [Related]
19. The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations. Grann VR, Jacobson JS, Sundararajan V, Albert SM, Troxel AB, Neugut AI. Cancer J Sci Am; 1999 Apr 12; 5(5):283-92. PubMed ID: 10526669 [Abstract] [Full Text] [Related]